Shripad S Bhagwat

USPTO Granted Patents = 43 (Patent Applications = 5)

CIPO Patents = 2 (Patent Applications = 20)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 4.7

ph-index = 13

Forward Citations = 564(Granted Patents)

Location History:

New York, NY (US) (1987)
Scotch Plains, NJ (US) (1988 - 1997)
Libertyville, IL (US) (1997 - 1999)
Lake Bluff, IL (US) (1998 - 2000)
San Diego, CA (US) (2000 - 2018)

Company Filing History:

19 out of 169

Signal Pharmaceuticals, Inc.

patents

9 out of 39

Ambit Biosciences Corporation

patents

5 out of 6,858

Ciba-geigy Corporation

patents

4. 3 out of 4,179

Abbott Laboratories Corporation

Ambit Bioscience Corporation

patent

9. 1 out of 27

Nippon Kayaku Co., Ltd

patents

where one patent can have more than one assignee

Years Active: 1987-2018

Loading Chart...

Areas of Expertise:

RAF Kinase Modulators

Imidazolothiazole Compounds

Anilinopyrimidine Derivatives

JNK Inhibitors

Estrogen Receptor Modulation

Benzopyranone Compounds

Neuroprotective Agents

Antiviral Ethers

Cyclic Hydrazine Compounds

Heterocyclic Compounds

Thromboxane A2 Synthesis

43 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10053430 - RAF kinase modulator compounds and methods of use thereof (2018-08-21),

2. 9730937 - RAF kinase modulator compounds and methods of use thereof (2017-08-15),

3. 9585892 - Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith (2017-03-07),

4. 9320739 - RAF kinase modulator compounds and methods of use thereof (2016-04-26),

5. 8969587 - RAF kinase modulator compounds and methods of use thereof (2015-03-03),

6. 8883783 - Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith (2014-11-11),

7. 8618289 - RAF kinase modulator compounds and methods of use thereof (2013-12-31),

8. 8557810 - Imidazolothiazole compounds for the treatment of disease (2013-10-15),

9. 8129374 - Method of using imidazolothiazole compounds for the treatment of disease (2012-03-06),

10. 7820657 - Imidazolothiazole compounds for the treatment of disease (2010-10-26),

11. 7442699 - Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto (2008-10-28),

12. 7429599 - Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK (2008-09-30),

13. 7335676 - Methods for treating inflammatory conditions or inhibiting JNK (2008-02-26),

14. 7279489 - Compounds and methods for modulation of estrogen receptors (2007-10-09),

15. 7247646 - Benzopyranone compounds, compositions thereof, and methods of treatment therewith (2007-07-24),

Title: The Innovative Journey of Shripad S Bhagwat

Introduction:

Shripad S Bhagwat is a renowned inventor based in San Diego, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Shripad S Bhagwat holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology.

Career Highlights:

With a career spanning over two decades, Shripad S Bhagwat has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized the industry.

Collaborations:

Throughout his career, Shripad S Bhagwat has collaborated with top scientists, engineers, and researchers to bring his innovative ideas to life. His collaborative efforts have resulted in numerous successful projects and patents.

Conclusion:

Shripad S Bhagwat's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in the tech world. His contributions continue to inspire the next generation of inventors and shape the future of technology.

This text is generated by artificial intelligence and may not be accurate.